Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Has Another Ace Up Its Sleeve
Seeking Alpha
Fri, 07/21/17 - 10:05 am
Tags:
Gilead Sciences, hepatitis C, Vosevi
FDA's Flashing Green Light Boosts Novel Drug Approvals
Seeking Alpha
Thu, 07/20/17 - 06:03 pm
Tags:
FDA, drug approvals, Gilead Sciences, Puma Biotechnology, Vosevi, Nerlynx
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
Wed, 07/19/17 - 07:55 pm
Tags:
AbbVie, Gilead Sciences, hepatitis C, Vosevi, Harvoni, Sovaldi, Epclusa, Viekira Pak
When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs
Forbes
Wed, 07/19/17 - 09:58 am
Tags:
drug pricing, hepatitis C, Martin Shkreli, Gilead Sciences, Harvoni, Sovaldi
5 Ways Gilead Sciences Could Spend Its Cash Hoard
Motley Fool
Wed, 07/19/17 - 09:29 am
Tags:
Gilead Sciences, dividends, share repurchase, M&A, debt
FDA OKs a new triple hep C drug from Gilead, keeping its grip on a shrinking market
Endpoints
Tue, 07/18/17 - 10:55 pm
Tags:
Gilead Sciences, FDA, hepatitis C, Vosevi
5 Big Pharma Stocks With the Best Drug Pipelines
Motley Fool
Tue, 07/18/17 - 11:32 am
Tags:
Big Pharma, Roche, AstraZeneca, AbbVie, Gilead Sciences, JNJ
These 3 Charts Don't Lie: Gilead Sciences Needs an Acquisition
Motley Fool
Mon, 07/17/17 - 08:49 am
Tags:
Gilead Sciences, M&A
Tesaro's rumored buyers aren't biting. Should Gilead go for Incyte instead?
Fierce Pharma
Sat, 07/15/17 - 11:14 am
Tags:
Tesaro, Gilead Sciences, Incyte, M&A
Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive
Endpoints
Fri, 07/14/17 - 11:28 am
Tags:
M&A, Gilead Sciences, Incyte, Vertex Pharmaceuticals, John Milligan
5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings
Yahoo/Zacks.com
Thu, 07/13/17 - 09:49 am
Tags:
earnings, Merck, Eli Lilly, Celgene, Gilead Sciences, Shire
Gilead faces revived lawsuit claiming it sidestepped FDA with HIV drug imports
Fierce Pharma
Mon, 07/10/17 - 11:32 pm
Tags:
Gilead Sciences, FDA, HIV, whistleblower lawsuits
What Gilead Could Learn From Celgene
Seeking Alpha
Mon, 07/10/17 - 11:15 am
Tags:
Gilead Sciences, Celgene
How Shrewd of a Dealmaker Is Gilead Sciences? Just Look at Its Last 7 Acquisitions
Motley Fool
Sun, 07/9/17 - 11:45 am
Tags:
Gilead Sciences, M&A, CV Therapeutics, CGI Pharma, Arresto Biosciences, Calistoga Pharmaceuticals, Pharmasset, YM BioSciences, EpiTherapeutics
3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals
Motley Fool
Mon, 07/3/17 - 11:18 am
Tags:
Gilead Sciences, Vertex Pharmaceuticals
Gilead's best M&A option? It's not oncology—it's Vertex, analyst insists
Fierce Pharma
Sat, 07/1/17 - 09:22 am
Tags:
Gilead Sciences, M&A, Vertex Pharmaceuticals
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
Tags:
prescription data, Sanofi, Lantus, Roche, Herceptin, Avastin, Celgene, Revlimid, JNJ, Merck, Remicade, Biogen, Rituxan, Amgen, Enbrel, Gilead Sciences, Harvoni, AbbVie, Humira
Gilead buy Vertex? A golden oldie in the M&A buzz circuit gets fresh air time
Endpoints
Fri, 06/30/17 - 10:48 am
Tags:
Gilead Sciences, Vertex Pharmaceuticals, M&A
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Tags:
Europe, EMA, hepatitis C, multiple sclerosis, breast cancer, renal cell carcinoma, AbbVie, Maviret, Gilead Sciences, Vosevi, Biogen, Amgen, Samsung Bioepis, biosimilars, Humira, Novartis, Kisqali, EUSA, Fotivda
5 Most Profitable Big Pharma Stocks on the Market Right Now
Motley Fool
Wed, 06/21/17 - 09:37 am
Tags:
Big Pharma, Gilead Sciences, Amgen, Novartis, Biogen, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.